KBL Merger Corp IV

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
KBL Merger Corp IV
TickerFRMM
CIK #0001690080
CUSIP68236V401
SectorReal Estate & Construction - Blank Checks
Address150 West 56th Street Suite 5901, New York, NY 10019
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Ethzilla Corp 2025-09-15 425.0 M Exemption: 506(b) · Duration: One year or less · Commission: $34,153,881 · Revenue: Decline to Disclose
180 Life Sciences Corp 2025-01-10 2.9 M Exemption: 506(b) · Duration: One year or less · Commission: $223,169 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001690080] 10-K
[0001690080] 10-Q
[0001690080] 3
[0001690080] 4
[0001690080] 8-K
[0001690080] D
[0001690080] SC 13D
[0001690080] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Zippy Inc /DE Ethzilla Corp [2025-12-15] 0.0
Hudson Bay Capital Management LP Ethzilla Corp [2025-11-12] 0.0
Pemble Brian James Ethzilla Corp [2025-10-15] 0.0
Electric Capital Partners Frontier Master Fund LP Ethzilla Corp [2025-10-02] 0.0
Cyber Citadel Ethzilla Corp [2025-10-01] 0.0
Steadfast Capital Management LP 180 Life Sciences Corp [2025-08-12] 0.0
FF Consumer Growth II LP 180 Life Sciences Corp [2025-08-11] 0.0
Amtrust Financial Services Inc 180 Life Sciences Corp [2025-04-16] 0.0
Jordan Blair 180 Life Sciences Corp [2025-02-25] 0.0
Anson Funds Management LP 180 Life Sciences Corp [2025-02-14] 0.0
Ayrton Capital LLC 180 Life Sciences Corp [2025-02-13] 0.0
Goodman Anthony Brian 180 Life Sciences Corp [2025-01-10] 0.0
Intracoastal Capital LLC 180 Life Sciences Corp [2025-01-03] 0.0
Feldmann Marc 180 Life Sciences Corp [2024-10-18] 8.6
Armistice Capital LLC 180 Life Sciences Corp [2024-02-14] 0.99
Vanguard Group Inc 180 Life Sciences Corp [2021-02-10] 6.54
Vanguard Index Funds 180 Life Sciences Corp [2021-02-08] 5.93
Bauer Ronald 180 Life Sciences Corp [2020-12-31] 0.2
Bridgman Craig 180 Life Sciences Corp [2020-12-29] 7.4
Nanchahal Jagdeep 180 Life Sciences Corp [2020-12-11] 5.3
Feldmann Marc 180 Life Sciences Corp [2020-11-18] 10.5
Mizuho Financial Group Inc KBL Merger Corp IV [2020-02-14] 5.2
Yakira Capital Management Inc KBL Merger Corp IV [2020-01-17] 0.43
Basso Capital Management LP KBL Merger Corp IV [2019-08-19] 6.5
Oxford Asset Management LLP KBL Merger Corp IV [2019-02-13] 6.96
Weiss Asset Management LP KBL Merger Corp IV [2019-02-01] 7.81
Weiss Asset Management LP KBL Merger Corp IV [2019-01-31] 6.13
AQR Capital Management LLC KBL Merger Corp IV [2018-02-14] 6.05
Boothbay Fund Management LLC KBL Merger Corp IV [2018-01-08] 5.99
Polar Asset Management Partners Inc KBL Merger Corp IV [2017-11-13] 11.72
Karpus Management Inc KBL Merger Corp IV [2017-08-11] 40.0
KBL IV Sponsor LLC KBL Merger Corp IV [2017-06-19] 24.2
Form 3/4/5 Filer 2011 - 2026
Pemble Brian James
ETHZilla Corp
Lomashuk Konstantin
Dalton Angela
Heter Crystal Jane
Rudisill McAndrew
New Jason Griffin
Edwards Michael A
Suckling Andrew P
Smith Ryan Lewis
Saunders John Tazewell
Elray Resources Inc
Shoemaker Stephen H
Jordan Blair
Steinman Lawrence
van Lent Eric R
Goodman Jay Lawrence
Jimenez Omar
Feldmann Marc
Woody James N
Ray Russell T
Rothbard Jonathan B
Francis Knuettel II
DeLuca Teresa
Gold Lawrence Marshall
Marrone Pamela G
McGovern Jr Donald A
Pamir Ozan
Vu Quan Anh
Krauss Marlene
KBL IV Sponsor LLC
Barker Richard W
Shendelman Shoshana
Oxford Asset Management LLP
Mizuho Securities USA LLC
Weiss Andrew M
WAM GP LLC
Weiss Asset Management LP
Polar Asset Management Partners Inc
Sherman Andrew
NEFF P Sherrill
Hornig George R
Williamson Joseph
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Smith Ryan Lewis
Common Stock
2026-02-18 Other 16,718 $0.00
Smith Ryan Lewis
Common Stock
2025-12-01 Gift 16,718 $0.00
Smith Ryan Lewis
Common Stock
2025-12-01 Gift 16,718 $0.00
Rudisill McAndrew
Common Stock
2025-11-14 Gift 410,865 $0.00
Rudisill McAndrew
Common Stock
2025-11-14 Gift 370,000 $0.00
Smith Ryan Lewis
Common Stock
2025-11-14 Gift 267,137 $0.00
Heter Crystal Jane
Common Stock
2025-11-14 Gift 182,742 $0.00
Smith Ryan Lewis
Common Stock
2025-11-14 Gift 267,137 $0.00
New Jason Griffin
Common Stock
2025-11-14 Gift 218,456 $0.00
New Jason Griffin
Common Stock
2025-11-14 Gift 218,456 $0.00
Suckling Andrew P
Common Stock
2025-11-14 Gift 149,020 $0.00
Heter Crystal Jane
Common Stock
2025-11-14 Gift 182,742 $0.00
Suckling Andrew P
Common Stock
2025-11-14 Gift 149,020 $0.00
Saunders John Tazewell
Common Stock
2025-11-12 Tax withheld 23,447 $0.00
Saunders John Tazewell
Common Stock
2025-11-12 Grant 109,312 $0.00
Rudisill McAndrew
Common Stock
2025-11-12 Tax withheld 271,635 $0.00
Rudisill McAndrew
Common Stock
2025-11-12 Grant 1,365,000 $0.00
Heter Crystal Jane
Common Stock
2025-11-12 Grant 649,748 $0.00
Heter Crystal Jane
Common Stock
2025-11-12 Tax withheld 142,132 $0.00
Suckling Andrew P
Common Stock
2025-11-12 Grant 649,748 $0.00
showing 20 of 197 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 47 12,104,428
2025-12-31 59 12,847,688
2025-09-30 3 12,577
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com